Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/107271
DC FieldValueLanguage
dc.contributor.authorClavo, Bernardinoen_US
dc.contributor.authorRobaina, Franciscoen_US
dc.contributor.authorUrrutia, Gerarden_US
dc.contributor.authorBisshopp, Saraen_US
dc.contributor.authorRamallo, Yolandaen_US
dc.contributor.authorSzolna, Adamen_US
dc.contributor.authorCaramés, Miguel A.en_US
dc.contributor.authorFiuza, María D.en_US
dc.contributor.authorLinertová, Renataen_US
dc.date.accessioned2021-05-24T14:11:12Z-
dc.date.available2021-05-24T14:11:12Z-
dc.date.issued2021en_US
dc.identifier.issn0965-2299en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/107271-
dc.description.abstractObjectives: Surgery is the treatment of choice for symptomatic disc herniation after conservative management. Several studies have suggested the potential utility of intradiscal ozone infiltration in this pathology. The aim of this trial was to compare intradiscal ozone infiltration vs. oxygen infiltration vs. surgery. Design and interventions: This was a randomized, double-blinded, and controlled trial in patients on a waiting list for herniated disc surgery. There were three treatment groups: surgery; intradiscal ozone infiltration (plus foraminal infiltration of ozone, steroids, and anesthetic); intradiscal oxygen infiltration (plus foraminal infiltration of oxygen, steroids, and anesthetic). Main outcome measures: The requirements for surgery. Results: Five years after the treatment of the last recruited patient (median follow-up: 78 months), the requirement for further surgery was 20 % for patients in the ozone group and 60 % for patients in the oxygen group. 11 % of patients initially treated with surgery also required a second surgery. Compared to the surgery group, the ozone group showed: 1) significantly lower number of inpatient days: median 3 days (interquartile range: 3–3.5 days) vs. 0 days (interquartile range: 0–1.5 days), p = 0.012; 2) significantly lower costs: median EUR 3702 (interquartile range: EUR 3283–7630) vs. EUR 364 (interquartile range: EUR 364–2536), p = 0.029. Conclusions: Our truncated trial showed that intradiscal ozone infiltrations decreased the requirements for conventional surgery, resulting in decreased hospitalization durations and associated costs. These findings and their magnitude are of interest to patients and health services providers. Further validation is ongoing.en_US
dc.languageengen_US
dc.relation.ispartofComplementary Therapies in Medicineen_US
dc.sourceComplementary Therapies in Medicine [ISSN 0965-2299], v. 59, 102724, (Junio 2021)en_US
dc.subject32 Ciencias médicasen_US
dc.subject3201 Ciencias clínicasen_US
dc.subject.otherCost-Effectivenessen_US
dc.subject.otherDisc Herniationen_US
dc.subject.otherMicrodiscectomyen_US
dc.subject.otherOzone Therapyen_US
dc.subject.otherRandomized Controlled Trialen_US
dc.titleOzone therapy versus surgery for lumbar disc herniation: A randomized double-blind controlled trialen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.ctim.2021.102724en_US
dc.identifier.scopus85105507347-
dc.contributor.authorscopusid57190093030-
dc.contributor.authorscopusid6603449723-
dc.contributor.authorscopusid7003560077-
dc.contributor.authorscopusid57200531623-
dc.contributor.authorscopusid35604397600-
dc.contributor.authorscopusid14032568700-
dc.contributor.authorscopusid6505906726-
dc.contributor.authorscopusid56698082300-
dc.contributor.authorscopusid26021346200-
dc.identifier.eissn1873-6963-
dc.relation.volume59en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages5en_US
dc.utils.revisionen_US
dc.date.coverdateJunio 2021en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,624
dc.description.jcr3,335
dc.description.sjrqQ1
dc.description.jcrqQ2
dc.description.scieSCIE
dc.description.miaricds10,9
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR SIANI: Ingeniería biomédica aplicada a estimulación neural y sensorial-
crisitem.author.deptIU Sistemas Inteligentes y Aplicaciones Numéricas-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0003-2522-1064-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU Sistemas Inteligentes y Aplicaciones Numéricas-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameClavo Varas,Bernardino-
crisitem.author.fullNameRobaina Padrón, Francisco-
crisitem.author.fullNameBisshopp Alfonso, Sara-
crisitem.author.fullNameRamallo Fariña, Yolanda-
crisitem.author.fullNameZbigniew Szolna,Adam-
crisitem.author.fullNameCaramés Álvarez,Miguel Angel-
crisitem.author.fullNameFiuza Pérez,Mª Dolores-
Appears in Collections:Artículos
Thumbnail
pdf
Adobe PDF (2,35 MB)
Show simple item record

SCOPUSTM   
Citations

7
checked on Jul 21, 2024

WEB OF SCIENCETM
Citations

6
checked on Jul 21, 2024

Page view(s)

74
checked on Jan 23, 2024

Download(s)

302
checked on Jan 23, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.